July 02, 2012
Mylan Inc. and Lupin Ltd. scored a victory Friday in a Teva Women's Health Inc. lawsuit over efforts to market generic versions of Teva's oral contraceptive Seasonique, when the sole patent claim being asserted by Teva was deemed invalid.